The Calamos Global Dynamic Income Fund (CHW) has been downgraded to a Hold rating due to concerns over rising interest rates and limited upside potential. Although CHW trades at a 9.45% discount to its net asset value and offers an 8.1% yield with strong dividend coverage, its net investment income remains weak. The fund's high leverage of 28.83% and focus on income-generating securities increase downside risk in a high-rate or falling equity market. The analyst suggests equity-focused alternatives like ADX may be better suited for income investors if rates stay high or equities decline.
Bitcoin balances on major exchanges increased notably, with a net inflow of over 1,100 BTC in 24 hours and more than 6,400 BTC over a month, reflecting growing sell-side readiness and trading activity. Binance saw a sharp rise in U.S. trading hours v...
Swedish Orphan Biovitrum (Sobi) and Innate Pharma have formed a strategic partnership to initiate the TELLOMAK-3 Phase 3 trial for lacutamab, targeting cutaneous T-cell lymphoma (CTCL), including Sézary syndrome. This trial is a key step toward accel...
ImmuPharma has appointed Kymos Group as the bioanalytical partner for its diabetes drug candidate Kapiglucagon, completing its outsourced development team. Kymos will develop and validate methods to measure the drug in biological samples and analyze ...
Bitcoin's 30-day demand has turned positive near 25,000 BTC after a sharp drop, signaling returning capital mainly driven by derivatives. However, for a sustainable recovery, stronger spot market participation is needed to absorb overhead supply and ...
ASM International N.V. has launched a share buyback program worth up to €150 million, starting August 10, 2026, and continuing until the total purchase reaches €150 million or by December 2026. The buyback is authorized by the company's management an...
